MMSI — Merit Medical Systems Inc. stock price and chart

Share this page

MMSI

$89.20-0.41%

as of close, Oct 16, 2026

☾ AH $89.20 -0.41%

Merit Medical Systems Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.01%Russell 3000 0.006%US Stock Market 0.005%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEE

20162019202120242026

30.040.050.060.070.080.090.0100.005.0M10.0M$89.20

2026-10-16

Price$89.20

MA20$77.48

MA50$79.67

Vol4.0M

What would $1,000 invested in MMSI be worth today? →

MMSI returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $89.20
YTD price return: +1.20%
YTD total return: +1.20%
Next earnings: Oct 29, 2026 · After close
Market cap: 5.3B2016-12 1.2B2026-10 5.3B+350.7% over the window
Enterprise value: 5.7B
Shares outstanding: 59.7M2016-06 44.4M2026-06 59.7M+34.5% over the window
52W low: $59.74
52W high: $94.75
From 52W high: -5.86%
From 52W low: +49.31%
52W range: 84%

Volume

Rel volume: 0.79×
30D volume: 612.5K
30D $ vol: 53.3M

Fundamentals

Sales (ttm): 1.6B2016-12 603.8M2026-06 1.6B+161.5% over the window
Sales/share: $26.442016-12 $13.522026-06 $26.44+95.5% over the window
EPS (ttm): $2.432016-06 $0.512026-06 $2.43+375.8% over the window
FCF (ttm): 203.2M2016-06 7.7M2026-06 203.2M+2537.3% over the window
FCF/share: $3.402016-06 $0.172026-06 $3.40+1860.8% over the window
Book value/share: $28.132016-06 $10.812026-06 $28.13+160.2% over the window
Net margin: 9.22%2016-12 3.3%2026-06 9.2%+176.7% over the window
ROE: 8.67%2016-06 4.8%2026-06 8.7%+81.9% over the window
ROA: 5.08%2016-06 2.8%2026-06 5.1%+81.1% over the window
Debt / equity: 0.44×2016-06 0.462026-06 0.44-5.1% over the window
Current ratio: 4.202016-06 2.592026-06 4.20+62.4% over the window

Growth (CAGR, ttm) · 10Y

Sales: +10.20%2025-06-30 → 2026-06-301.4B → 1.6B (+10.2% total)+9.63%2023-06-30 → 2026-06-301.2B → 1.6B (+31.8% total)+8.89%2021-06-30 → 2026-06-301B → 1.6B (+53.1% total)+10.65%2016-12-31 → 2026-06-30603.8M → 1.6B (+161.5% total)
Net income: +22.21%2025-06-30 → 2026-06-30119.1M → 145.6M (+22.2% total)+17.54%2023-06-30 → 2026-06-3089.6M → 145.6M (+62.4% total)+38.82%2021-06-30 → 2026-06-3028.2M → 145.6M (+415.4% total)+20.34%2016-06-30 → 2026-06-3022.9M → 145.6M (+536.5% total)
FCF: +5.67%2025-06-30 → 2026-06-30192.3M → 203.2M (+5.7% total)+61.19%2023-06-30 → 2026-06-3048.5M → 203.2M (+318.9% total)+8.44%2021-06-30 → 2026-06-30135.5M → 203.2M (+50.0% total)+38.72%2016-06-30 → 2026-06-307.7M → 203.2M (+2537.3% total)
Shares: +0.83%2025-06-30 → 2026-06-3059.2M → 59.7M (+0.8% total)+1.19%2023-06-30 → 2026-06-3057.6M → 59.7M (+3.6% total)+1.19%2021-06-30 → 2026-06-3056.3M → 59.7M (+6.1% total)+3.01%2016-06-30 → 2026-06-3044.4M → 59.7M (+34.5% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +23.27%2025-06-30 → 2026-06-30$1.97 → $2.43 (+23.3% total)+16.26%2023-06-30 → 2026-06-30$1.54 → $2.43 (+57.2% total)+37.16%2021-06-30 → 2026-06-30$0.50 → $2.43 (+385.3% total)+16.88%2016-06-30 → 2026-06-30$0.51 → $2.43 (+375.8% total)
Sales/share: +9.29%2025-06-30 → 2026-06-30$24.20 → $26.44 (+9.3% total)+8.34%2023-06-30 → 2026-06-30$20.79 → $26.44 (+27.2% total)+7.61%2021-06-30 → 2026-06-30$18.33 → $26.44 (+44.3% total)+7.32%2016-12-31 → 2026-06-30$13.52 → $26.44 (+95.5% total)
FCF/share: +4.80%2025-06-30 → 2026-06-30$3.25 → $3.40 (+4.8% total)+59.30%2023-06-30 → 2026-06-30$0.84 → $3.40 (+304.4% total)+7.17%2021-06-30 → 2026-06-30$2.41 → $3.40 (+41.3% total)+34.67%2016-06-30 → 2026-06-30$0.17 → $3.40 (+1860.8% total)
Book value/share: +11.97%2025-06-30 → 2026-06-30$25.13 → $28.13 (+12.0% total)+10.44%2023-06-30 → 2026-06-30$20.88 → $28.13 (+34.7% total)+9.79%2021-06-30 → 2026-06-30$17.64 → $28.13 (+59.5% total)+10.04%2016-06-30 → 2026-06-30$10.81 → $28.13 (+160.2% total)
Price: +10.39%2025-10-16 → 2026-10-16$80.81 → $89.20 (+10.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+10.53%2023-10-16 → 2026-10-16$66.05 → $89.20 (+35.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+5.09%2021-10-15 → 2026-10-16$69.59 → $89.20 (+28.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+14.16%2016-10-14 → 2026-10-16$23.72 → $89.20 (+276.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +10.39%2025-10-16 → 2026-10-16$80.81 → $89.20 (+10.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+10.53%2023-10-16 → 2026-10-16$66.05 → $89.20 (+35.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+5.09%2021-10-15 → 2026-10-16$69.59 → $89.20 (+28.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+14.16%2016-10-14 → 2026-10-16$23.72 → $89.20 (+276.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 36.8×2016-12 62.112026-10 36.59-41.1% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 26.4×2016-12 38.962026-10 26.45-32.1% over the window
Fwd P/E: 18.9×
P/S (ttm)Market cap ÷ TTM revenue.: 3.4×2016-12 3.292026-10 3.37+2.6% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 3.2×2016-12 2.432026-10 3.17+30.4% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 26.2×2016-12 108.992026-10 26.21-76.0% over the window
EV/EBITDA (fy): 17.5×
EV/Sales (ttm): 3.6×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 3.82%2016-09 0.9%2026-06 4.9%+434.9% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 59.7M ÷ 59.2M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.83%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.83%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($5.5B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -0.83%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-12.8M) ÷ today's market cap ($5.3B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: -0.24%2016-09 -0.4%2026-06 -0.3%-29.2% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-12.8M + TTM dividends $0) ÷ today's market cap ($5.3B). Same caveat as the cash buyback yield.: -0.24%2016-09 -0.4%2026-06 -0.3%-29.2% over the window

Vs own 10Y history

P/E: 6th
P/OI: 7th
P/S: 52nd
P/B: 38th
P/FCF: 15th

Bar = where today’s multiple sits in MMSI’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-0.41%

+2.28%

+3.55%

+18.07%

YTD

+1.20%

+10.38%

+28.18%

Financial statements

Open full MMSI financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

MMSI — Merit Medical Systems Inc. price, chart and key statistics